Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.22 -0.89 (-2.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

28 29 Next >

Goodbye Open Seating! Southwest Airlines Announces Major Policy Shift. ↗

July 25, 2024

Southwest Airlines is making major changes to its boarding policy as the air travel company is getting rid of open seating next year.

Via InvestorPlace

Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials ↗

July 25, 2024

Viking Therapeutics stock is up on Thursday as VKTX investors react to the company preparing for a Phase 3 trial of its weight loss drug.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 25, 2024

Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!

Via InvestorPlace

Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 25, 2024

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,600 Today ↗

July 23, 2024

Via Benzinga

Smart Money Is Betting Big In VKTX Options ↗

July 18, 2024

Via Benzinga

Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity ↗

July 05, 2024

Via Benzinga

Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks ↗

July 25, 2024

It takes a special set of circumstances for high-growth stocks to double in value in one year but analyst says these three can do it.

Via InvestorPlace

Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

July 24, 2024

On Wednesday, major U.S. indices closed significantly lower. The Dow Jones Industrial Average fell 1.25% to 39,853.87.

Via Benzinga

Topics Stocks

VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q2 2024 ↗

July 24, 2024

VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Viking Therapeutics Stock Climbs On Q2 EPS Beat ↗

July 24, 2024

Viking Therapeutics shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the key figures from the report:

Via Benzinga

Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon. ↗

July 22, 2024

Eli Lilly is still a smart pick, but these two stocks could grow more in the near term.

Via The Motley Fool

3 Monster Stocks in the Making to Buy Right Now ↗

July 20, 2024

They're small now, but these stocks could grow much larger.

Via The Motley Fool

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review ↗

July 19, 2024

The Nasdaq tumbled amid chip woes.

Via Investor's Business Daily

3 Undervalued Biotech Stocks With Breakout Potential ↗

July 19, 2024

Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements

Via InvestorPlace

Is Viking Therapeutics a Millionaire-Maker? ↗

July 19, 2024

This biotech stock fits the profile of a potentially big winner to a T.

Via The Motley Fool

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗

July 18, 2024

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.

Via Benzinga

3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition ↗

July 18, 2024

These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late.

Via InvestorPlace

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? ↗

July 17, 2024

Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest...

Via Benzinga

Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There' ↗

July 17, 2024

Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde.

Via Benzinga

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 17, 2024

Via Benzinga

Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data ↗

July 17, 2024

Roche released early-stage data on its oral weight-loss drug.

Via Investor's Business Daily

Is Viking Therapeutics the Best Biotech Stock for You? ↗

July 17, 2024

Let's look beyond the hype the company is generating this year.

Via The Motley Fool

The 3 Most Undervalued Biotech Stocks to Buy in July 2024 ↗

July 12, 2024

There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment.

Via InvestorPlace

Is Viking Therapeutics Stock Running Out of Steam? ↗

July 11, 2024

Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today.

Via The Motley Fool

Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics ↗

July 10, 2024

Both competitors have promising lead programs, and enough cash, too.

Via The Motley Fool

Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug

July 09, 2024

Global pharmaceutical company Eli Lilly & Co. (NYSE: LLY) has been in a GLP-1 arms race with its FDA-approved therapies Mounjaro and Zepbound. It's been

Via MarketBeat

Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half? ↗

July 09, 2024

This pharma company is posting double-digit revenue growth.

Via The Motley Fool

3 Overlooked Giants-in-the-Making for Patient Investors ↗

July 08, 2024

Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches.

Via InvestorPlace

The 7 Best Under $10 Stocks to Buy in July 2024 ↗

July 06, 2024

We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now.

Via InvestorPlace

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today